Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/8635041/ below:

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute

Affiliations

• ¹ Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco 94143-0746, USA.

• PMID: 8635041
• DOI: 10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#

Item in Clipboard

C Zippin et al. Cancer. 1995.

• ¹ Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco 94143-0746, USA.

• PMID: 8635041
• DOI: 10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#

Item in Clipboard

Background: To ascertain the quality of data entering a population-based reporting system, an essential requirement is to study levels of completeness of case-ascertainment and reporting. This study represents an effort to quantify completeness of case reporting in the SEER (Surveillance, Epidemiology, and End Results) Program of the National Cancer Institute.

Methods: Hospitals in each of the participating SEER areas were stratified according to their annual hospital cancer caseload for the year 1987. Within each caseload stratum, a random sample of hospitals was selected for inclusion in this study. Files in the medical record, pathology, and radiation oncology departments in each hospital were reviewed for SEER reportable cases. These cases were then matched against SEER case listings to identify unreported cases.

Results: The crude estimated completeness of reporting for 1987 in the six participating SEER areas was 97.7% and the registry-caseload standardized rate was 96.8%. Variation was noted by SEER registry, hospital cancer caseload, and casefinding source (hospital department). Three-quarters of unreported cases were of invasive disease and one-fourth were in situ, primarily of the cervix uteri.

Conclusions: There is variation in completeness of casefinding among SEER registries, hospital size, and hospital department source. Additional factors that appear to be related to case ascertainment are cancer site or type and who performs the casefinding function (hospital registry or central registry staff).

PubMed Disclaimer

• Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.

  Zakaria D, Shaw A, Woods R, De P, Davis F. Zakaria D, et al. J Registry Manag. 2018 Fall;45(1):117-131. J Registry Manag. 2018. PMID: 31017881

• Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.

  Kim HM, Goodman M, Kim BI, Ward KC. Kim HM, et al. J Registry Manag. 2011 Autumn;38(3):120-31. J Registry Manag. 2011. PMID: 22223054

• The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.

  Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. Duggan MA, et al. Am J Surg Pathol. 2016 Dec;40(12):e94-e102. doi: 10.1097/PAS.0000000000000749. Am J Surg Pathol. 2016. PMID: 27740970 Free PMC article. Review.

• The surveillance, epidemiology, and end results program: a national resource.

  Hankey BF, Ries LA, Edwards BK. Hankey BF, et al. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1117-21. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10613347 Review. No abstract available.

• An international comparison of breast cancer survival: Winnipeg, Manitoba and Des Moines, Iowa, metropolitan areas.

  Gorey KM, Kliewer E, Holowaty EJ, Laukkanen E, Ng EY. Gorey KM, et al. Ann Epidemiol. 2003 Jan;13(1):32-41. doi: 10.1016/s1047-2797(02)00259-4. Ann Epidemiol. 2003. PMID: 12547483 Free PMC article.

• Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.

  Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Buchholz TA, et al. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1022-7. doi: 10.1016/j.ijrobp.2007.11.036. Epub 2008 Jan 30. Int J Radiat Oncol Biol Phys. 2008. PMID: 18234447 Free PMC article.

• An exploration for quantification of overdiagnosis and its effect for breast cancer screening.

  Yang L, Wang S, Huang Y. Yang L, et al. Chin J Cancer Res. 2020 Feb;32(1):26-35. doi: 10.21147/j.issn.1000-9604.2020.01.04. Chin J Cancer Res. 2020. PMID: 32194302 Free PMC article.

• Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data.

  Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Friese CR, et al. Cancer. 2009 Feb 15;115(4):716-24. doi: 10.1002/cncr.24085. Cancer. 2009. PMID: 19152430 Free PMC article.

• Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status.

  Polednak AP. Polednak AP. J Natl Med Assoc. 1998 Feb;90(2):101-4. J Natl Med Assoc. 1998. PMID: 9510624 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3